Adjuvant Chemotherapy for Stage I Pancreatic Ductal Adenocarcinoma-Is It Based on Evidence or Clinical Wisdom?

JAMA Oncol. 2021 Dec 1;7(12):1759-1760. doi: 10.1001/jamaoncol.2021.3603.

Authors

Lorenzo Gervaso^{1

2}, Florian Lordick³, Nicola Fazio¹

Affiliations

¹ Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy.
² Molecular Medicine Program, University of Pavia, Pavia, Italy.
³ Department of Oncology, Gastroenterology, Hepatology, Pulmonology, and Infectious Diseases, University Cancer Center Leipzig, Leipzig University Medical Center, Leipzig, Germany.

PMID: 34617958
DOI: 10.1001/jamaoncol.2021.3603

No abstract available

MeSH terms

Carcinoma, Pancreatic Ductal* / drug therapy
Chemotherapy, Adjuvant
Humans
Pancreatic Neoplasms* / drug therapy